C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/61 (2006.01) A61K 31/44 (2006.01) C07D 213/34 (2006.01) C07D 213/65 (2006.01) C07D 213/70 (2006.01) C07D 213/75 (2006.01) C07D 213/78 (2006.01) C07D 213/80 (2006.01) C07D 213/85 (2006.01) C07D 213/89 (2006.01)
Patent
CA 2260016
The invention encompasses the novel compound of formula (I) as well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of formula (I). The invention also encompasses certain pharmaceutical compositions for treatment of COX-2 mediated diseases comprising compounds of formula (I).
L'invention concerne le nouveau composé de la formule (I) de même qu'un procédé de traitement des maladies induites par COX-2, lequel consiste à administrer à un patient nécessitant un tel traitement une dose non toxique et efficace sur le plan thérapeutique d'un composé de la formule (I). L'invention concerne également certaines compositions pharmaceutiques destinées au traitement de maladies induites par COX-2, et comprenant les composés de la formule (I).
Dube Daniel
Fortin Rejean
Friesen Richard
Merck Frosst Canada Incorporated
Merck Frosst Canada Ltd.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Substituted pyridines as selective cyclooxygenase-2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyridines as selective cyclooxygenase-2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyridines as selective cyclooxygenase-2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1727211